首页> 外文期刊>Alborz University Medical Journal >Treatment Results of Combined Surgery and Brachytherapy, and the Rate of Recurrence in Patients with Recurrent Keloid Scars
【24h】

Treatment Results of Combined Surgery and Brachytherapy, and the Rate of Recurrence in Patients with Recurrent Keloid Scars

机译:复发性瘢痕loid瘢痕的联合外科近距离治疗的治疗结果及复发率

获取原文
       

摘要

Background: Several options are described to treat keloid scars, none of them being 100% successful. Radiotherapy is suggested to have the most significant effect on recurrence rate. The aim of the study is to evaluate the effectiveness of High-dose brachytherapy combined with surgery and to evaluate patient satisfaction. Methods and Material: We retrospectively enrolled 5 patients with 10 keloids, treated by surgical excision and high-dose-rate (HDR) brachytherapy. Total dose was 12 Gy in 3 fractions. Results: The median size of the lesions before brachytherapy was 153.48 mm2. The improvement of scars of scoring POSAS by observer and patient were 17.1±3.2 (11-32) and 20.8±11.5 (5-51), respectively. Mean of recurrent time was 26.3±0.9 months. With a median follow-up of 60 months, the overall recurrence-free response rate for all keloids was 20%. Except for one patient, in other patients seen no complications. Conclusion: It seems that keloid excision followed by HDR brachytherapy is effective in the eradication of keloids in treatment. It also resulted in a good cosmetic rate and relief of symptoms.
机译:背景:描述了几种治疗瘢痕loid疤痕的方法,但都没有100%成功。建议放疗对复发率影响最大。该研究的目的是评估大剂量近距离放射疗法与手术相结合的有效性,并评估患者的满意度。方法和材料:我们回顾性研究了5例10种瘢痕loid的患者,这些患者接受了手术切除和高剂量率(HDR)近距离放射治疗。总剂量为3个分数的12 Gy。结果:近距离放射治疗前病变的中位大小为153.48 mm2。观察者和患者对POSAS评分疤痕的改善分别为17.1±3.2(11-32)和20.8±11.5(5-51)。平均复发时间为26.3±0.9个月。中位随访60个月,所有瘢痕loid的总无复发反应率为20%。除一名患者外,其他患者均未见并发症。结论:瘢痕loid切除加HDR近距离放射治疗可有效根除瘢痕effective。这也导致了良好的美容率并减轻了症状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号